Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient

Lauren Fontana, Lynne Strasfeld

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Respiratory virus infections in hematologic stem cell transplant recipients and patients with hematologic malignancies are increasingly recognized as a cause of significant morbidity and mortality. The often overlapping clinical presentation makes molecular diagnostic strategies imperative for rapid diagnosis and to inform understanding of the changing epidemiology of each of the respiratory viruses. Most respiratory virus infections are managed with supportive therapy, although there is effective antiviral therapy for influenza. The primary focus should remain on primary prevention infection control procedures and isolation precautions, avoidance of ill contacts, and vaccination for influenza.

Original languageEnglish (US)
Pages (from-to)523-544
Number of pages22
JournalInfectious Disease Clinics of North America
Volume33
Issue number2
DOIs
StatePublished - Jun 2019

Keywords

  • Coronavirus
  • Hematopoietic stem cell transplant
  • Human metapneumovirus
  • Influenza
  • Parainfluenza
  • RSV
  • Respiratory virus infection
  • Rhinovirus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient'. Together they form a unique fingerprint.

Cite this